7. Share ownership information

7.1 Shareholdings of members of the Board of Directors

The tables in this section are audited by the external auditor.

The following table shows the equity of the individual members of the Board of Directors and persons closely linked to them.

	31.03.2022				31.03.2021
	Shares	Restricted Shares 1)	RSUs	Options	Shares	Restricted Shares 2)	RSUs	Options
Robert F. Spoerry, Chair	44,368	12,261			41,227	14,293
Stacy Enxing Seng, Vice-Chair	4,744	4,319			3,231	5,353
Lynn Dorsey Bleil, Member	1,543	4,319			30	5,353
Gregory (Greg) Behar, Member 3)		479
Lukas Braunschweiler, Member	26,490	2,967	700	96,016	25,007	2,488	2,183	96,016
Roland Diggelmann, Member 3)		479
Ronald van der Vis, Member	1,513	4,319			3,231	5,353
Jinlong Wang, Member	6,159	4,319			4,846	5,353
Adrian Widmer, Member		1,210				731
Total (active members)	84,817	34,672	700	96,016	77,572	38,924	2,183	96,016
Beat Hess, Vice-Chair 4)					6,691	5,353
Michael Jacobi, Member 5)						5,353
Total (including former members)	84,817	34,672	700	96,016	84,263	49,630	2,183	96,016

1) These shares are subject to a restriction period which varies from June 1, 2022 to June 1, 2027 depending on the grant date.

2) These shares are subject to a restriction period which varies from June 1, 2021 to June 1, 2026 depending on the grant date.

3) New member of the Board of Directors since June 2021.

4) Vice-Chair of the Board of Directors until June 2021.

5) Member of the Board of Directors until June 2021.

For further details see also Note 7.4 in the consolidated financial statements.

The shareholding requirements set by the share ownership guidelines are entirely met by all members of the Board of Directors.

7.2 Shareholdings of members of the Management Board

The tables in this section are audited by the external auditor.

The following tables show the equity of individual members of the Management Board and persons closely linked to them.

	31.03.2022				31.03.2021
	Shares 1)	PSUs	RSUs	Options	Shares 1)	PSUs	RSUs	Options
Arnd Kaldowski	14,597	9,627		189,888	6,792	11,581		173,017
Birgit Conix 2)	195	991		4,655
Ludger Althoff	1,183	2,241	528	18,421	919	1,659	792	17,448
Claudio Bartesaghi	911	2,494		23,227 3)	681	2,865	73	22,401 3)
Vicky Carr-Brendel	474	2,206	474	17,603 4)	237	1,617	711	16,413 4)
Claude Diversi	655	2,977	817	21,724	1,057	4,831	881	27,272
Christophe Fond	776	3,855	323	40,187	4,236	5,005	933	36,682
Martin Grieder	1,506	3,567	316	47,160	1,006	4,765	912	51,812
Andi Vonlanthen	21,292	3,462	316	54,558	17,174	4,831	912	65,727
Total (active members)	41,589	31,420	2,774	417,423	32,102	37,154	5,214	410,772
Hartwig Grevener 5)					9,420	1,854	596	20,210
Total (including former members)	41,589	31,420	2,774	417,423	41,522	39,008	5,810	430,982

1) Shares are dividend entitled with full voting rights.

2) Member of the Management Board since June 2021.

3) includes SARs (SARs grant the right to participate in the appreciation of Sonova shares without issuance of shares).

4) SARs were granted instead of options (SARs grant the right to participate in the appreciation of Sonova shares without issuance of shares).

5) Member of the Management Board until June 2021.

For further details see also Note 7.4 in the consolidated financial statements.

The shareholding requirements set by the share ownership guidelines are entirely met by all members of the Management Board.

The following table shows the shareholding requirements relative to the fixed base salary and the indicative actual shareholdings.


	Base salary	Share requirements 1)	Actual shares 2)	Fulfillment of share ownership guidelines	Share ownership ratio to base salary
	in CHF	in CHF	in CHF	in %	ratio
Arnd Kaldowski, CEO	900,000	1,000,000	5,657,797	566	6.3
Other members of the MB 3)	385,474	200,000	1,483,788	742	3.8

1) Share requirements to be achieved for the CEO as of December 31, 2017 and for all other members of the MB after 41 months.

2) Calculated with Sonova closing share price of March 31, 2022.

3) Average of other members of the MB with shareholding requirements.

The calculation of fulfillment and the ratio to base salary of the share ownership shown above are included for illustration purposes only.

The following table shows a detailed breakdown of the outstanding options of the members of the Management Board.

	31.03.2022
		Options EEAP 22 1)	Options EEAP 21 2)	Options EEAP 20 3)	Options EEAP 19 4)	Options EEAP 18 5)	Options EEAP 17 6)	Options EEAP 16 7)	Total options
Arnd Kaldowski		16,871	25,454	28,119	32,901	86,543 9)			189,888
Birgit Conix 8)		4,655							4,655
Ludger Althoff		2,734	4,736	5,668	5,283				18,421
Claudio Bartesaghi		2,355	4,210	4,649	4,881	4,984	2,148 10)		23,227
Vicky Carr-Brendel		2,769 11)	4,699 11)	5,398 11)	4,737 11)				17,603 11)
Claude Diversi		2,381	5,639	6,748	4,307	2,649			21,724
Christophe Fond		3,505	5,889	7,048	8,996	8,127	6,622		40,187
Martin Grieder		3,085	5,513	6,598	8,422	10,594	12,948		47,160
Andi Vonlanthen		2,278	5,639	6,748	8,614	10,594	12,948	7,737	54,558
Total (active members)		40,633	61,779	70,976	78,141	123,491	34,666	7,737	417,423
Hartwig Grevener 12)
Total (including former members)		40,633	61,779	70,976	78,141	123,491	34,666	7,737	417,423

1) Exercise price CHF 333.60, vesting period 1.2.2022–1.6.2026 whereas one tranche being vested each year, end of restriction period 31.1.2027, exercise period 1.2.2027–31.1.2032.

2) Exercise price CHF 218.70, vesting period 1.2.2021–1.6.2025 whereas one tranche being vested each year, end of restriction period 31.1.2026, exercise period 1.2.2026–31.1.2031.

3) Exercise price CHF 241.80, vesting period 1.2.2020–1.6.2024 whereas one tranche being vested each year, end of restriction period 31.1.2025, exercise period 1.2.2025–31.1.2030.

4) Exercise price CHF 182.40, vesting period 1.2.2019–1.6.2023 whereas one tranche being vested each year, exercise period 1.6.2020–31.1.2029.

5) Exercise price CHF 147.85, vesting period 1.2.2018–1.6.2022 whereas one tranche being vested each year, exercise period 1.6.2019–31.1.2028.

6) Exercise price CHF 130.00, vesting period 1.2.2017–1.6.2021 whereas one tranche being vested each year, exercise period 1.6.2018–31.1.2024.

7) Exercise price CHF 124.20, vesting period 1.2.2016–1.6.2020 whereas one tranche being vested each year, exercise period 1.6.2017–31.1.2023.

8) Member of the Management Board since June 2021.

9) Includes the one-time, non-recurring performance option grant (47,415 options); exercise price of CHF 147.85, vesting period of 1.2.2018 – 1.4.2025, exercise period 1.4.2023 – 30.9.2027.

10) SARs EEAP 2017 (SARs grant the right to participate in the appreciation of Sonova shares without issuance of shares).

11) SARs were granted instead of options (SARs grant the right to participate in the appreciation of Sonova shares without issuance of shares).

12) Member of the Management Board until June 2021.

	31.03.2021
		Options EEAP 21 1)	Options EEAP 20 2)	Options EEAP 19 3)	Options EEAP 18 4)	Options EEAP 17 5)	Options EEAP 16 6)	Options EEAP 15 7)	Total options
Arnd Kaldowski		25,454	28,119	32,901	86,543 8)				173,017
Hartwig Grevener			1,649	4,211	5,297	6,474	2,579		20,210
Ludger Althoff		4,736	5,668	7,044					17,448
Claudio Bartesaghi		4,210	4,649	4,881	4,984	2,148 9)	1,529		22,401
Vicky Carr-Brendel		4,699 10)	5,398 10)	6,316 10)					16,413 10)
Claude Diversi		5,639	6,748	6,461	5,297	3,127			27,272
Christophe Fond		5,889	7,048	8,996	8,127	6,622			36,682
Martin Grieder		5,513	6,598	8,422	10,594	12,948	7,737		51,812
Andi Vonlanthen		5,639	6,748	8,614	10,594	12,948	10,315	10,869	65,727
Total		61,779	72,625	87,846	131,436	44,267	22,160	10,869	430,982

1) Exercise price CHF 218.70, vesting period 1.2.2021–1.6.2025 whereas one tranche being vested each year, end of restriction period 31.1.2026, exercise period 1.2.2026–31.1.2031.

2) Exercise price CHF 241.80, vesting period 1.2.2020–1.6.2024 whereas one tranche being vested each year, end of restriction period 31.1.2025, exercise period 1.2.2025–31.1.2030.

3) Exercise price CHF 182.40, vesting period 1.2.2019–1.6.2023 whereas one tranche being vested each year, exercise period 1.6.2020–31.1.2029.

4) Exercise price CHF 147.85, vesting period 1.2.2018–1.6.2022 whereas one tranche being vested each year, exercise period 1.6.2019–31.1.2028.

5) Exercise price CHF 130.00, vesting period 1.2.2017–1.6.2021 whereas one tranche being vested each year, exercise period 1.6.2018–31.1.2024.

6) Exercise price CHF 124.20, vesting period 1.2.2016–1.6.2020 whereas one tranche being vested each year, exercise period 1.6.2017–31.1.2023.

7) Exercise price CHF 121.10, vesting period 1.2.2015–1.6.2019 whereas one tranche being vested each year, exercise period 1.6.2016–31.1.2022.

8) Includes the one-time, non-recurring performance option grant (47,415 options); exercise price of CHF 147.85, vesting period of 1.2.2018 – 1.4.2023, exercise period 1.4.2023 – 30.9.2027.

9) SARs EEAP 2017 (SARs grant the right to participate in the appreciation of Sonova shares without issuance of shares).

10) SARs were granted instead of options (SARs grant the right to participate in the appreciation of Sonova shares without issuance of shares).

Glossary

AC Audit Committee
AGM Annual General Shareholders’ Meeting
AHV Old Age and Survivorsʼ Insurance
ALV Unemployment Insurance
Articles of Association Articles of Association of Sonova Holding AG
ASP Average Sales Price
BoD Board of Directors
CEO Chief Executive Officer
CFO Chief Financial Officer
CHF Swiss Francs
EBITA Earnings Before Interest, Taxes and Amortization
EEAP Executive Equity Award Plan
EPS Earnings Per Share
ESG Environmental, Social and Governance
FCF Free Cash Flow
GVP Group Vice President
HRM Human Resource Management
KPIs Key Performance Indicators
MB Management Board
n.a. Not applicable
NCC Nomination and Compensation Committee
OPEX Operating Expenses
PSU Performance Share Unit
ROCE Return on Capital Employed
RSU Restricted Share Unit
rTSR relative Total Shareholder Return
SLI Swiss Leaders Index
SMI Swiss Market Index
SMIM Swiss Market Index Mid
VCC Variable Cash Compensation